120 related articles for article (PubMed ID: 986268)
1. [Quantitative studies of neurons of the substantia nigra and basal ganglia in parkinsonism].
Togi H; Ogawa M; Yamanouchi H; Tomonaga M; Kameyama M
Rinsho Shinkeigaku; 1976 Apr; 16(4):311-8. PubMed ID: 986268
[No Abstract] [Full Text] [Related]
2. Clinical and pathological features of corticobasal degeneration.
Gibb WR; Luthert PJ; Marsden CD
Adv Neurol; 1990; 53():51-4. PubMed ID: 2239491
[No Abstract] [Full Text] [Related]
3. Implications of alterations in trace element levels in brain in Parkinson's disease and other neurological disorders affecting the basal ganglia.
Dexter DT; Sian J; Jenner P; Marsden CD
Adv Neurol; 1993; 60():273-81. PubMed ID: 8420143
[No Abstract] [Full Text] [Related]
4. [Clinico-pathomorphologic correlations in parkinsonism].
Starikov AS; Obraztsova RG; Kleĭn AV
Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(12):28-32. PubMed ID: 6762023
[No Abstract] [Full Text] [Related]
5. Magnetic resonance imaging-based volumetric analysis of basal ganglia nuclei and substantia nigra in patients with Parkinson's disease.
Geng DY; Li YX; Zee CS
Neurosurgery; 2006 Feb; 58(2):256-62; discussion 256-62. PubMed ID: 16462479
[TBL] [Abstract][Full Text] [Related]
6. [A 78-year-old man with young onset parkinsonism and sudden death].
Miyasaka H; Mori H; Saikawa T; Shirai T; Kondo T; Imai H; Mizuno Y
No To Shinkei; 1996 May; 48(5):487-95. PubMed ID: 8672309
[TBL] [Abstract][Full Text] [Related]
7. Clinical and neurochemical consequences of neuronal loss in the nucleus basalis of Meynert in Parkinson's disease and Alzheimer's disease.
Whitehouse PJ
Adv Neurol; 1987; 45():393-7. PubMed ID: 2881448
[No Abstract] [Full Text] [Related]
8. The pathology of Parkinsonism. Part I. Some new observations and correlations.
Forno LS; Alvord EC
Contemp Neurol Ser; 1971; 8():119-30. PubMed ID: 5162177
[No Abstract] [Full Text] [Related]
9. Calbindin-D28k in the basal ganglia of patients with parkinsonism.
Ito H; Goto S; Sakamoto S; Hirano A
Ann Neurol; 1992 Oct; 32(4):543-50. PubMed ID: 1456738
[TBL] [Abstract][Full Text] [Related]
10. Functional neuroanatomy of the basal ganglia in Parkinson's disease.
Wichmann T; DeLong MR
Adv Neurol; 2003; 91():9-18. PubMed ID: 12442660
[No Abstract] [Full Text] [Related]
11. Ultrastructural chemoanatomy of the basal ganglia: an overview.
Pasik P; Pasik T; Holstein GR
Adv Neurol; 1987; 45():59-66. PubMed ID: 2881451
[No Abstract] [Full Text] [Related]
12. Quantitative 1H magnetic resonance spectroscopy and MRI of Parkinson's disease.
O'Neill J; Schuff N; Marks WJ; Feiwell R; Aminoff MJ; Weiner MW
Mov Disord; 2002 Sep; 17(5):917-27. PubMed ID: 12360540
[TBL] [Abstract][Full Text] [Related]
13. Parkinson's disease is a neuropsychiatric disorder.
Agid Y; Arnulf I; Bejjani P; Bloch F; Bonnet AM; Damier P; Dubois B; François C; Houeto JL; Iacono D; Karachi C; Mesnage V; Messouak O; Vidailhet M; Welter ML; Yelnik J
Adv Neurol; 2003; 91():365-70. PubMed ID: 12442695
[No Abstract] [Full Text] [Related]
14. [The origin of Parkinson's disease].
Rinne J
Duodecim; 1997; 113(18):1819-24. PubMed ID: 10892075
[No Abstract] [Full Text] [Related]
15. Pathological changes in dendrites of substantia nigra neurons in Parkinson's disease: a Golgi study.
Patt S; Gertz HJ; Gerhard L; Cervós-Navarro J
Histol Histopathol; 1991 Jul; 6(3):373-80. PubMed ID: 1725760
[TBL] [Abstract][Full Text] [Related]
16. [The neuropathology of Parkinson syndrome].
Gray F
Rev Neurol (Paris); 1988; 144(4):229-48. PubMed ID: 2843979
[TBL] [Abstract][Full Text] [Related]
17. Expression profiling of substantia nigra in Parkinson disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonism.
Hauser MA; Li YJ; Xu H; Noureddine MA; Shao YS; Gullans SR; Scherzer CR; Jensen RV; McLaurin AC; Gibson JR; Scott BL; Jewett RM; Stenger JE; Schmechel DE; Hulette CM; Vance JM
Arch Neurol; 2005 Jun; 62(6):917-21. PubMed ID: 15956162
[TBL] [Abstract][Full Text] [Related]
18. Clinical neuropathological conference.
Dis Nerv Syst; 1967 Jun; 28(6):407-12. PubMed ID: 6033181
[No Abstract] [Full Text] [Related]
19. Molecular neuroanatomic mechanisms of Parkinson's disease: a proposed therapeutic approach.
Gerfen CR; Engber TM
Neurol Clin; 1992 May; 10(2):435-49. PubMed ID: 1350051
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II receptor binding associated with nigrostriatal dopaminergic neurons in human basal ganglia.
Allen AM; MacGregor DP; Chai SY; Donnan GA; Kaczmarczyk S; Richardson K; Kalnins R; Ireton J; Mendelsohn FA
Ann Neurol; 1992 Sep; 32(3):339-44. PubMed ID: 1416803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
